Greenphire Celebrates its Tenth Inclusion on the Inc. 5000 List of Fastest Growing Companies
As the demand for participant flexibility and administrative automation in clinical research continues to skyrocket, the leader in financial workflow optimization for global trials continues to disrupt and modernize the industry
KING OF PRUSSIA, Pa., August 15, 2023 — Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, today announced its inclusion on the Inc. 5000 list for 2023. This represents the tenth instance in 15 years in which the company’s unwavering market expansion has been acknowledged and honored. The prestigious Inc. 5000 nomination commemorates the most rapidly growing private organizations in the country, applauding their exceptional leadership and entrepreneurial drive.
Greenphire continues to see growth across its patient convenience solutions as sites, sponsors, and CROs are increasingly seeking to leverage digital tools to drive participant engagement. Supporting more than 4 million participants, including an 84% increase in number of study visit rides booked over the past 12 months, ClinCard, the leading technology for participant reimbursement automation, combined with ConneX global participant travel service, continue to be the industry preferred patient convenience offerings. The company’s recently launched patient-facing digital platform, GreenSpace enables sponsors, CROs and sites to deliver an even more seamless and centralized experience for participants everywhere, ensuring greater diversity, inclusion and accessibility.
Across nearly 80 countries, Greenphire’s budgeting and site payment tools, EnvisiX and eClinicalGPS, continue to optimize financial and administrative processes throughout the trial lifecycle. Enabling faster study startup times, improved transparency & control and standardized payment processes, the company has streamlined traditionally manual workflows for more than 30,000 research sites along with top sponsors and CROs.
“We are incredibly proud and deeply honored to have been recognized for the 10th time on Inc.’s 5000 list of the most innovative companies. This remarkable achievement serves as a true testament to the unwavering dedication and relentless drive of our team in revolutionizing the industry,” said Jim Murphy, CEO, Greenphire. “We remain steadfast in our commitment to pushing boundaries and creating impactful solutions that truly remove the barriers to clinical research success and medical advancement.
Greenphire will be honored at the Inc. 5000 Conference & Gala, taking place October 31-November 2, 2023, in San Antonio. To learn more about Greenphire and its solutions, visit: Greenphire.com.
Greenphire’s suite of best-in-class technology solutions enables clients to prioritize the patient journey, so treatments and cures can be delivered to those who need them faster.
Committed to modernizing and integrating each step in the participant journey and the overall clinical trial lifecycle, Greenphire has established an unmatched suite of patient convenience solutions, including a mobile-enabled technology platform which offers a personalized and empowering end-to-end participant experience from trial identification through participation. ClinCard® and ConneX® remove financial and logistical barriers, simplifying the delivery of global patient convenience initiatives and improving recruitment and retention. Greenphire’s EnvisiX™ and eClinicalGPS® transform the budgeting and site payment process, resulting in expedited study start up and improved site sustainability. Learn more at www.greenphire.com